Sumatriptan Succinate Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 20 pharmaceutical companies such as ONESOURCE SPECIALTY, MERIDIAN MEDCL, ZYDUS and others. It is marketed under 8 brand names, including SUMATRIPTAN SUCCINATE, ALSUMA, ZECUITY and others. Available in 10 different strengths, such as EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML), EQ 50MG BASE, EQ 100MG BASE and others, and administered through 5 routes including INJECTABLE;SUBCUTANEOUS, TABLET;ORAL, SYSTEM;IONTOPHORESIS and others.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 20 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"41166","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ONZETRA XSAIL","family_id":"249c0e7d0fe343e2a7b3","publication_number":"US7975690B2","cleaned_patent_number":"7975690","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-08-18","publication_date":"2011-07-12","legal_status":"Granted"} US7975690B2 Formulation 12 Jul, 2011 Granted 18 Aug, 2025
{"application_id":"69016","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ONZETRA XSAIL","family_id":"02522960695747249cb2","publication_number":"US9108015B2","cleaned_patent_number":"9108015","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-09-15","publication_date":"2015-08-18","legal_status":"Expired"} US9108015B2 Formulation 18 Aug, 2015 Expired 15 Sep, 2025
{"application_id":"68981","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ONZETRA XSAIL","family_id":"02522960695747249cb2","publication_number":"US8590530B2","cleaned_patent_number":"8590530","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-09-15","publication_date":"2013-11-26","legal_status":"Granted"} US8590530B2 Formulation 26 Nov, 2013 Granted 15 Sep, 2025
{"application_id":"69038","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ONZETRA XSAIL","family_id":"1c8e76164c7c4de6be38","publication_number":"US11571531B2","cleaned_patent_number":"11571531","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-02-23","publication_date":"2023-02-07","legal_status":"Granted"} US11571531B2 07 Feb, 2023 Granted 23 Feb, 2026
{"application_id":"101095","ingredient":"NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE","trade_name":"TREXIMET","family_id":"b8497a850a7a4f929691","publication_number":"US7332183B2","cleaned_patent_number":"7332183","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-04-02","publication_date":"2008-02-19","legal_status":"Granted"} US7332183B2 19 Feb, 2008 Granted 02 Apr, 2026
{"application_id":"63035","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"SUMAVEL DOSEPRO","family_id":"8eb699dbef814da28314","publication_number":"US7901385B2","cleaned_patent_number":"7901385","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-07-31","publication_date":"2011-03-08","legal_status":"Expired"} US7901385B2 Formulation 08 Mar, 2011 Expired 31 Jul, 2026
{"application_id":"63010","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"SUMAVEL DOSEPRO","family_id":"340e5acf96f44b3886b1","publication_number":"US7776007B2","cleaned_patent_number":"7776007","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-11-22","publication_date":"2010-08-17","legal_status":"Expired"} US7776007B2 Formulation 17 Aug, 2010 Expired 22 Nov, 2026
{"application_id":"41377","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ONZETRA XSAIL","family_id":"aa10e409fd4d45b7a73e","publication_number":"US10124132B2","cleaned_patent_number":"10124132","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-03-06","publication_date":"2018-11-13","legal_status":"Granted"} US10124132B2 Formulation 13 Nov, 2018 Granted 06 Mar, 2027
{"application_id":"83411","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ZECUITY","family_id":"a3eee6da51224751a904","publication_number":"US8597272B2","cleaned_patent_number":"8597272","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-04-12","publication_date":"2013-12-03","legal_status":"Expired"} US8597272B2 Formulation 03 Dec, 2013 Expired 12 Apr, 2027
{"application_id":"83412","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ZECUITY","family_id":"a3eee6da51224751a904","publication_number":"US9427578B2","cleaned_patent_number":"9427578","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-04-12","publication_date":"2016-08-30","legal_status":"Expired"} US9427578B2 Formulation 30 Aug, 2016 Expired 12 Apr, 2027
{"application_id":"83375","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ZECUITY","family_id":"cc4aef59b9a54f869ac9","publication_number":"US7973058B2","cleaned_patent_number":"7973058","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-04-12","publication_date":"2011-07-05","legal_status":"Expired"} US7973058B2 05 Jul, 2011 Expired 12 Apr, 2027
{"application_id":"83398","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ZECUITY","family_id":"a3eee6da51224751a904","publication_number":"US8155737B2","cleaned_patent_number":"8155737","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-04-12","publication_date":"2012-04-10","legal_status":"Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362"} US8155737B2 10 Apr, 2012 Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362 12 Apr, 2027
{"application_id":"83392","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ZECUITY","family_id":"cc4aef59b9a54f869ac9","publication_number":"US8470853B2","cleaned_patent_number":"8470853","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-04-12","publication_date":"2013-06-25","legal_status":"Granted"} US8470853B2 25 Jun, 2013 Granted 12 Apr, 2027
{"application_id":"62985","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ALSUMA","family_id":"65d729deea6e47f49e76","publication_number":"US7811254B2","cleaned_patent_number":"7811254","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-08-26","publication_date":"2010-10-12","legal_status":"Granted"} US7811254B2 Formulation 12 Oct, 2010 Granted 26 Aug, 2027
{"application_id":"83393","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ZECUITY","family_id":"cc4aef59b9a54f869ac9","publication_number":"US9272137B2","cleaned_patent_number":"9272137","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-09-07","publication_date":"2016-03-01","legal_status":"Expired"} US9272137B2 Formulation 01 Mar, 2016 Expired 07 Sep, 2027
{"application_id":"69017","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ONZETRA XSAIL","family_id":"02522960695747249cb2","publication_number":"US10398859B2","cleaned_patent_number":"10398859","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-12-19","publication_date":"2019-09-03","legal_status":"Granted"} US10398859B2 Formulation 03 Sep, 2019 Granted 19 Dec, 2027
{"application_id":"68973","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ONZETRA XSAIL","family_id":"401c4f9ba0294df1b6ae","publication_number":"US8875704B2","cleaned_patent_number":"8875704","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-04-07","publication_date":"2014-11-04","legal_status":"Granted"} US8875704B2 Formulation 04 Nov, 2014 Granted 07 Apr, 2028
{"application_id":"68976","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ONZETRA XSAIL","family_id":"401c4f9ba0294df1b6ae","publication_number":"US10722667B2","cleaned_patent_number":"10722667","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-12-30","publication_date":"2020-07-28","legal_status":"Granted"} US10722667B2 Formulation 28 Jul, 2020 Granted 30 Dec, 2028
{"application_id":"83417","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ZECUITY","family_id":"76351e3c893f46628f7c","publication_number":"US8366600B2","cleaned_patent_number":"8366600","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-04-21","publication_date":"2013-02-05","legal_status":"Granted"} US8366600B2 05 Feb, 2013 Granted 21 Apr, 2029
{"application_id":"41324","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ONZETRA XSAIL","family_id":"dc47e558813747588111","publication_number":"US10076615B2","cleaned_patent_number":"10076615","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-07-30","publication_date":"2018-09-18","legal_status":"Granted"} US10076615B2 18 Sep, 2018 Granted 30 Jul, 2029
{"application_id":"41381","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ONZETRA XSAIL","family_id":"aa10e409fd4d45b7a73e","publication_number":"US8550073B2","cleaned_patent_number":"8550073","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-10-22","publication_date":"2013-10-08","legal_status":"Granted"} US8550073B2 Formulation 08 Oct, 2013 Granted 22 Oct, 2029
{"application_id":"69022","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ONZETRA XSAIL","family_id":"c8ffc78c18914803ba81","publication_number":"US8899229B2","cleaned_patent_number":"8899229","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-08-18","publication_date":"2014-12-02","legal_status":"Granted"} US8899229B2 Formulation 02 Dec, 2014 Granted 18 Aug, 2030
{"application_id":"68975","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ONZETRA XSAIL","family_id":"401c4f9ba0294df1b6ae","publication_number":"US9649456B2","cleaned_patent_number":"9649456","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-21","publication_date":"2017-05-16","legal_status":"Granted"} US9649456B2 Formulation 16 May, 2017 Granted 21 Oct, 2030
{"application_id":"83437","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ZECUITY","family_id":"558489be4c66429294b4","publication_number":"US8983594B2","cleaned_patent_number":"8983594","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-19","publication_date":"2015-03-17","legal_status":"Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362"} US8983594B2 Formulation 17 Mar, 2015 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 19 Nov, 2030
{"application_id":"41331","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ONZETRA XSAIL","family_id":"dc47e558813747588111","publication_number":"US8978647B2","cleaned_patent_number":"8978647","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-12-06","publication_date":"2015-03-17","legal_status":"Granted"} US8978647B2 Formulation 17 Mar, 2015 Granted 06 Dec, 2030
{"application_id":"83464","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ZECUITY","family_id":"679762b6eb4b4b24a7a3","publication_number":"US9327114B2","cleaned_patent_number":"9327114","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-10-08","publication_date":"2016-05-03","legal_status":"Granted"} US9327114B2 Formulation 03 May, 2016 Granted 08 Oct, 2032
{"application_id":"41336","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ONZETRA XSAIL","family_id":"f7d8111279a249c1a353","publication_number":"US10478574B2","cleaned_patent_number":"10478574","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-11-04","publication_date":"2019-11-19","legal_status":"Granted"} US10478574B2 19 Nov, 2019 Granted 04 Nov, 2033
{"application_id":"41429","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ONZETRA XSAIL","family_id":"8d5a1cd8babf44d89a44","publication_number":"US10076614B2","cleaned_patent_number":"10076614","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-10-20","publication_date":"2018-09-18","legal_status":"Granted"} US10076614B2 Formulation 18 Sep, 2018 Granted 20 Oct, 2034
{"application_id":"80431","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ZEMBRACE SYMTOUCH","family_id":"200e2874f27f4e3bb307","publication_number":"US10537554B2","cleaned_patent_number":"10537554","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-01-29","publication_date":"2020-01-21","legal_status":"Patented case"} US10537554B2 21 Jan, 2020 Patented case 29 Jan, 2036
{"application_id":"80437","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ZEMBRACE SYMTOUCH","family_id":"200e2874f27f4e3bb307","publication_number":"US11364224B2","cleaned_patent_number":"11364224","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-01-29","publication_date":"2022-06-21","legal_status":"Granted"} US11364224B2 21 Jun, 2022 Granted 29 Jan, 2036
{"application_id":"138507","ingredient":"SUMATRIPTAN SUCCINATE","trade_name":"ZEMBRACE SYMTOUCH","family_id":"200e2874f27f4e3bb307","publication_number":"US12097183B2","cleaned_patent_number":"12097183","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-01-29","publication_date":"2024-09-24","legal_status":"Granted"} US12097183B2 Formulation 24 Sep, 2024 Granted 29 Jan, 2036

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Sumatriptan Succinate

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.